Literature DB >> 19597112

Trends in annual medicare expenditures for glaucoma surgical procedures from 1997 to 2006.

Jordana K Schmier1, David W Covert, Edmund C Lau, Alan L Robin.   

Abstract

OBJECTIVE: To identify payments and changes in payments for glaucoma surgical procedures among Medicare beneficiaries in the United States and to evaluate trends in costs based on the types of procedures being performed.
DESIGN: Retrospective analysis using 1997 through 2006 Part B Medicare Beneficiary Encrypted Files. The annual number of claims and payments for glaucoma surgical procedures were calculated, as were the rates per 100 000 beneficiaries.
RESULTS: Overall, there were decreases in both the number of glaucoma surgical procedures and the amount of annual payments from 1997 to 2001 but an increase in the number of procedures in the following years. Trends in claims and payments vary according to procedure. Average payments for trabeculectomies decreased over time, while annual payments for cyclophotocoagulation and shunt-related procedures have increased. After an initial decline, there was a substantial increase in the number of trabeculoplasties in conjunction with advancements in technology and a change in the global period for reimbursement. Patterns of surgery rates were similar to volume of surgical procedures.
CONCLUSIONS: Findings suggest that while the overall number of glaucoma surgical procedures is increasing, payments have been decreasing. Clinical and technological advancements and reimbursement decisions may influence surgeons' preferences and, therefore, costs to Medicare.

Entities:  

Mesh:

Year:  2009        PMID: 19597112     DOI: 10.1001/archophthalmol.2009.122

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN: 0003-9950


  14 in total

1.  Intensive diabetes therapy and ocular surgery in type 1 diabetes.

Authors:  Lloyd Paul Aiello; Wanjie Sun; Arup Das; Sapna Gangaputra; Szilard Kiss; Ronald Klein; Patricia A Cleary; John M Lachin; David M Nathan
Journal:  N Engl J Med       Date:  2015-04-30       Impact factor: 91.245

2.  Medicare costs for neovascular age-related macular degeneration, 1994-2007.

Authors:  Shelley Day; Kofi Acquah; Paul P Lee; Prithvi Mruthyunjaya; Frank A Sloan
Journal:  Am J Ophthalmol       Date:  2011-08-16       Impact factor: 5.258

Review 3.  Novel drug delivery systems for glaucoma.

Authors:  E Lavik; M H Kuehn; Y H Kwon
Journal:  Eye (Lond)       Date:  2011-04-08       Impact factor: 3.775

4.  Changes in Visual Function in the Elderly Population in the United States: 1995-2010.

Authors:  Yiqun Chen; Paul Hahn; Frank A Sloan
Journal:  Ophthalmic Epidemiol       Date:  2016-05-04       Impact factor: 1.648

5.  Global rates of glaucoma surgery.

Authors:  Kaweh Mansouri; Felipe A Medeiros; Robert N Weinreb
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2013-09-26       Impact factor: 3.117

6.  What are the clinical, quality-of-life, and cost consequences of 30 years of excellent vs. poor glycemic control in type 1 diabetes?

Authors:  William H Herman; Barbara H Braffett; Shihchen Kuo; Joyce M Lee; Michael Brandle; Alan M Jacobson; Lisa A Prosser; John M Lachin
Journal:  J Diabetes Complications       Date:  2018-06-12       Impact factor: 2.852

7.  Temporal trends in pre-surgical evaluations and epilepsy surgery in the U.S. from 1998 to 2009.

Authors:  Nicholas K Schiltz; Siran M Koroukian; Samden D Lhatoo; Kitti Kaiboriboon
Journal:  Epilepsy Res       Date:  2012-08-02       Impact factor: 3.045

8.  Trabeculectomy and Combined Phacoemulsification-Trabeculectomy: Outcomes and Risk Factors for Failure in Primary Angle Closure Glaucoma.

Authors:  Brian J Song; Meera Ramanathan; Esteban Morales; Simon K Law; JoAnn A Giaconi; Anne L Coleman; Joseph Caprioli
Journal:  J Glaucoma       Date:  2016-09       Impact factor: 2.503

9.  FRIENDS Group: clinical and microbiological characteristics of post-filtering surgery endophthalmitis.

Authors:  E Brillat-Zaratzian; A Bron; F Aptel; J P Romanet; P L Cornut; F Vandenesch; S Boisset; M Maurin; C Chiquet
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2013-11-19       Impact factor: 3.117

10.  Two-year treatment patterns and costs in glaucoma patients initiating treatment with prostaglandin analogs.

Authors:  Jordana K Schmier; Edmund C Lau; David W Covert
Journal:  Clin Ophthalmol       Date:  2010-10-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.